Evolva Holding SA (SIX: EVE), a pioneer and global leader in sustainable, fermentation-based approaches to ingredients for health, wellness and nutrition has agreed to acquire San Diego-based Allylix, Inc., a privately held yeast fermentation company with a focus on high-value ingredients, in an all-stock transaction. The acquisition will immediately expand Evolva's product and IP portfolio and enhance the competitiveness of Evolva's stevia products. The overall consideration will consist in 46 million newly-issued Evolva shares (c. 14.1% of Evolva post transaction). Cargill, Inc., Evolva's partner on its stevia programm, will invest USD 4 million in Evolva shares in support of the transaction.

Homburger acted as Swiss counsel to Evolva in this transaction. The Homburger team consisted of partner Hansjürg Appenzeller (Corporate | M&A | Financial Services), associate Sergio Bortolani and junior associate Kevin Hubacher (both Corporate | M&A).